Walsh C, Holschneider C, Hoang Y, Tieu K, Karlan B, Cass I. Co-existing ovarian malignancy in young women with endometrial cancer. Obstet Gynecol. 2005;106:693-9.

Walsh CS, Miller CW, Karlan BY, Koeffler HP. Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk. Gynecol Oncol. 2007;104(3):660-4.Epub 2006 Nov 21.

Walsh CS, Ogawa S, Karahashi H, Scoles DR, Pavelka JC, Tran H, Miller CW, Kawamata N, Ginther C, Dering J, Sanada M, Nannya Y, Slamon DJ, Koeffler PH, Karlan BY. ERCC5 (XPG) is a novel biomarker of ovarian cancer prognosis. J Clin Oncol. 2008;26(18):2952-8. .

Walsh CS, Ogawa S, Scoles DR, Miller CW, Kawamata N, Narod SA, Koeffler HP, Karlan BY. Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian carcinomas. Clin Can Res. 2008;14(23):7645-51. 

Walsh C, Karlan BY. Molecular signatures of ovarian cancer: from detection to prognosis. Molecular Diagnosis & Ther. 2010;14(1):13-22. 

Walsh CS, Blum A, Walts A, Alsabeh R, Tran H, Koeffler HP, Karlan BY. Lynch Syndrome among gynecologic oncology patients meeting Bethesda Guidelines for screening. Gynecol Oncol. 2010;116(3):516-21. Epub 2010 Jan 19.

Fleming ND, Lentz SE, Cass I, Li AJ, Karlan BY, Walsh CS. Is older age a poor prognostic factor in stage I and II endometrioid endometrial adenocarcinoma? Gynecol Oncol. 2011;120(2):189-92. Epub 2010 Nov 26. 

Fleming ND, Agadjanian H, Nassanian H, Miller CW, Orsulic S, Karlan BY, Walsh CS. Xeroderma pigmentosum complementation group C single nucleotide polymorphisms in the NER pathway correlate with prolonged progression-free survival in advanced ovarian cancer. Cancer. 2012;118(3):689-97. Epub ahead of print 2011 Jul 12.

Taylor-Harding B, Agadjanian H, Nassanian H, Kwon S, Guo X, Miller C, Karlan BY, Orsulic S, Walsh CS. Indole-3-carbinol synergistically sensitizes ovarian cancer cells to bortezomib treatment. Br J Cancer. 2012;106(2):333-43.Epub 2011 Dec 13.PMID: 22166800.

ElMasri W, Walts AE, Chiang A, Walsh CS. Predictors of invasive adenocarcinoma after conization for cervical adenocarcinoma in situ. Gynecol Oncol. 2012;125(3):589-93.Epub 2012 Mar 9.